Analyst consensus rating
Tyra Biosciences Analyst Rating: Strong Buy
TYRA is rated Strong Buy by 11 analysts with a $50.82 target. As of 2026-09-01.
Direct answer
Tyra Biosciences's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $50.82.
Forecast evidence checked September 1, 2026.
Get free Tyra Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $25.03
- Average price target
- $50.82
- High price target
- $59.00
- Low price target
- $39.00
- Low target gap
- +55.8%
- Target upside
- +103%
- High target gap
- +135.7%
- Target range width
- 79.9%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- September 1, 2026
- Valid through
- September 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tyra Biosciences?
Tyra Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $50.82.
How far are Tyra Biosciences's low and high targets from the recorded price?
The low target implies +55.8%, while the high target implies +135.7%.
How many analysts are included in Tyra Biosciences's consensus?
The verified consensus includes 11 analysts.
How is Tyra Biosciences's target upside or downside calculated?
The average target of $50.82 is divided by the recorded price of $25.03, then one is subtracted to produce +103%. This does not guarantee a future return.
When was Tyra Biosciences's analyst forecast verified?
The data was verified on 2026-09-01. The dataset is valid through 2026-09-08.